Kilitch Drugs (India) share news and announcements
NSE: KILITCHBSE: 524500Pharmaceuticals & BiotechnologySmall Cap
Last close ₹202.24up ₹0.13 (0.06%)BSE ₹203.50
Share price at the NSE close on 23 Oct 2026. Previous close ₹202.11.
52-week range of traded prices to 23 Oct 2026
₹117.25Low, 30 Mar 2026₹267.90High, 7 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹707 Cr1,776th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 23.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 15 May 2026
- 2.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 12.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 8.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 15 May 2026
- 0.32
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,44,52347.0% delivered
Kilitch Drugs (India) share news and announcements
492 announcements, routine notices left out, newest first. Page 10 of 10.
Sep 2012
Aug 2012
30 Aug · Corporate action
Board of Directors of the Company at its meeting held on August 30, 2012 has finalized the Record Date for the purpose of Special Interim Dividend as September 25, 2012 to determine the Members of the Company who shall be entitled to said Special Interim Dividend.30 Aug · Meeting
Annual General Meeting of the Members of the Company will be held on September 29, 2012.30 Aug · Dividend
Board of Directors of the Company at its meeting held on August 30, 2012 has declared Special Interim dividend @ 300% (i.e. Rs.30/- per equity share of Rs.10/- each) on the equity shares of the Company.25 Aug · Board meeting
(1) To recommend Special Interim Dividend on equity shares of the Company; (2) To fix the record date for the purpose of Special Interim Dividend; (3) To take on record the Audited Consolidated Financial Results of the Company for the year ended March 31, 2012; (4) To adopt and approve the Notice & Directors Report of the Company along with the Corporate Governance Report for financial year 2011-12; (5) To finalize the date, venue and time for convening Annual General Meeting of the Members of the Company; (6) Any other matter with the permission of the Chair.1 Aug · Board meeting
To transact the following business : (1) To take on record the Unaudited (Provisional) Financial Results for the Quarter ended June 30, 2012 along with Limited Review Report; (2) Any other matter with the permission of the Chair.
May 2012
3 May · Board meeting
To transact the following business : (1) To take on record the Unaudited (Provisional) Financial Results for the Quarter ended March 31, 2012; (2) Any other matter with the permission of the Chair.
Feb 2012
Jan 2012
24 Jan · Board meeting
1) To take on record the Unaudited(Provisional) Financial Results for the Quarter ended December 31, 2011; 2) Any other matter with the permission of the Chair.
Nov 2011
3 Nov · Board meeting
To transact the following business : (1) To take on record the Unaudited (Provisional) Financial Results for the Quarter ended September 30, 2011; (2) Any other matter with the permission of the Chair.
Oct 2011
Sep 2011
Aug 2011
4 Aug · Board meeting
To transact the following business : (1) To take on record the Unaudited (Provisional) Financial Results for the Quarter ended June 30, 2011; (2) Any other matter with the permission of the Chair.3 Aug · Meeting
Kilitch Drugs (India) Limited had informed the Exchange that the Annual General Meeting of the Company will be held on August 30, 2011. The Company has now informed the Exchange that "The working Directors of the Company, who are well versed and have firsthand information and knowledge about the business operations of the Company unfortunately will not be in a position to attend the said AGM due to sudden business exigencies, which cannot be avoided. Further, the presence of such working Directors in the said AGM is all more important in order to answer any queries and in particular, about the operations of the Company, that may be raised by shareholders of the Company. Also, any queries raised by the members about future business plans can be well attended to only by such Directors who oversee day to day business operations of the Company. In view of the above, it is proposed to extend the date of Annual General Meeting from August 30, 2011 to September 10, 2011". Further the Company has informed that the dates of book closures as intimated remains unchanged from August 23, 2011 to August 30, 2011 [both days inclusive].
Jul 2011
29 Jul · Management
Board of Directors of the Company at its meeting held on July 25, 2011 has accepted the resignation tendered by Mr. Nitin. C. Shah from the Directorship of the Company w.e.f. July 25, 2011.27 Jul · Meeting
Book Closure for forthcoming Annual General Meeting and for the purpose of dividend is from August 23, 2011 to August 30, 2011 (both days inclusive). Further the Annual General Meeting of the Company will be held on August 30, 2011.27 Jul · Dividend
Board of Directors of the Company at its meeting held on July 25, 2011 has recommended payment of dividend @ Re.1/- per equity share of Rs.10/- each for the year ended March 31, 2011 subject to the approval of the Members at the ensuing Annual General Meeting.18 Jul · Board meeting
(1) To take on record the Audited Consolidated Financial Results of the Company for the year ended March 31, 2011; (2) To recommend dividend on equity shares of the Company subject to approval of the members at the ensuing Annual General Meeting; (3) To adopt and approve the Notice & Directors Report of the Company along with the Corporate Governance Report for financial year 2010-11; (4) To finalize the dates of Book Closure for the purpose of forthcoming Annual General Meeting and dividend; (5) To finalize the date, venue and time for convening Annual General Meeting of the Members of the Company; (6) Any other matter with the permission of the Chair.
May 2011
5 May · Board meeting
To transact the following business : (1) To take on record the Unaudited (Provisional) Financial Results for the Quarter ended March 31, 2011; (2) Any other matter with the permission of the Chair.
Feb 2011
14 Feb · Business
In the Meeting of the Board of Directors of the Company held on February 14, 2011, it was decided to allot 15750 shares against the exercise of Employee Stock Option under ESOS KDL 2007 at a price @Rs.47.50.2 Feb · Board meeting
(1) To take on record the Unaudited (Provisional) Financial Results for the Quarter ended December 31,2010. (2) To consider allotment of shares against exercise of employee stock option under ESOS KDL 2007 as approved by the shareholders of the Company at their Extra Ordinary General Meeting held on May 31, 2010.
Dec 2010
27 Dec · Rating
Company has been awarded 'A-' rating by CRISIL for its Finance Related Facilities, which reaffirms stable status of the Company.
Nov 2010
Oct 2010
28 Oct · Board meeting
1) To take on record the Unaudited (Provisional) Financial Results for the Quarter ended September 30, 2010; 2) Any other matter with the permission of the Chair.18 Oct · Business
At the Board Meeting held on October 16, 2010, it was decided to allot shares against the exercise of Employee Stock Option under ESOS KDL 2007 at a price @ Rs. 47.50.11 Oct · Board meeting
1) To consider allotment of shares against exercise of employee stock option under ESOS KDL 2007 as approved by the shareholders of the Company at their Extra Ordinary General Meeting held on May 31, 2010. 2)Any other matter with the permission of the Chair.
Sep 2010
30 Sep · Corporate action
Board of Directors of the Company has fixed October 15, 2010 as the Record Date for the purpose of payment of dividend @ 10% (Rs.1/- per share) on 13202122 equity shares of Rs.10/- each for the financial year 2009-2010 and which was approved by the members of the Company at the Annual General Meeting held on September 20, 2010.